Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3
Closed 378
2019
Q1
$0 Hold
3
﹤0.01% 415
2018
Q4
$0 Sell
3
-47
-94% -$9.17K ﹤0.01% 426
2018
Q3
$10K Hold
50
﹤0.01% 355
2018
Q2
$9K Hold
50
﹤0.01% 375
2018
Q1
$9K Sell
50
-50
-50% -$9.18K ﹤0.01% 375
2017
Q4
$17K Sell
100
-40
-29% -$7.08K 0.01% 323
2017
Q3
$26K Hold
140
0.01% 276
2017
Q2
$24K Buy
+140
New +$22.8K 0.01% 280

Other funds holding AMGN

Bell Rock Capital's AMGN Position: Q2 2019 in Review

Bell Rock Capital sold out of Amgen (AMGN) in Q2 2019, closing a stake of 3 shares.

Bell Rock Capital first reported a position in AMGN in Q2 2017 and held it in 8 quarters. The position peaked at $26K in Q3 2017. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Bell Rock Capital reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Bell Rock Capital sold 3 Amgen shares in Q2 2019.
  • Bell Rock Capital first reported a position in Amgen in Q2 2017 and held it in 8 quarters.
  • Bell Rock Capital's Amgen position peaked at $26K in Q3 2017.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Bell Rock Capital's 13F filing for Q2 2019, filed 31 Jul 2019.